SCHEMBL4926320

SCHEMBL4926320

CNc1cc(Cl)cc(COc2c(Cl)cc(C(=O)NCC(=O)O)cc2Cl)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.40
GAA P10253 2/20 0.40
KDM4E B2RXH2 2/20 0.40
MRGPRX4 Q96LA9 1/20 0.39
MEN1 O00255 2/20 0.38
RAB9A P51151 2/20 0.38
KMT2A Q03164 2/20 0.38
LMNA P02545 2/20 0.38
NPC1 O15118 1/20 0.38
ABL1 P00519 1/20 0.38
MAPT P10636 1/20 0.38
HPGD P15428 1/20 0.38
RIN1 Q13671 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
PLAU P00749 1/20 0.38
HSD17B10 Q99714 1/20 0.38
ITGB3 P05106 1/20 0.37
ITGA2B P08514 1/20 0.37
TSHR P16473 1/20 0.37
TDP1 Q9NUW8 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5717786 0.95 THRA (0.38) ALDH1A1GAAKDM4EMRGPRX4MEN1
SCHEMBL4931530 0.90 SMN1; SMN2 (0.43) MEN1RAB9AKMT2ALMNANPC1
SCHEMBL4929428 0.90 ALDH1A1 (0.39) ALDH1A1GAAKDM4EMRGPRX4MEN1
SCHEMBL5109415 0.89 MEN1 (0.39) ALDH1A1GAAKDM4EMRGPRX4MEN1
SCHEMBL4934497 0.89 HSD17B10 (0.39) ALDH1A1GAAKDM4EMRGPRX4MEN1
SCHEMBL4932562 0.89 ALDH1A1 (0.39) ALDH1A1GAAKDM4EMRGPRX4MEN1
SCHEMBL4926987 0.89 THRA (0.41) ALDH1A1GAAKDM4EMRGPRX4MEN1
SCHEMBL5117190 0.87 MEN1 (0.40) ALDH1A1GAAKDM4EMRGPRX4MEN1
SCHEMBL4932637 0.87 HSD17B10 (0.40) ALDH1A1GAAKDM4EMRGPRX4MEN1
SCHEMBL4932507 0.86 RAB9A (0.47) ALDH1A1GAAKDM4EMRGPRX4MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080221210-A1 Thyroid Receptor Agonists KARO BIO AB (SE) 2008-09-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080221210-A1 Thyroid Receptor Agonists TSHR, TRHR, THRA ALDH1A1 1818/4885GAA 4551/4885KDM4E 1703/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.